Description
Wiseguyreports.Com Adds “Nanopharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database
Nanopharmaceuticals are colloidal particles of 10 to 1,000 nanometers (1 micron) in size. They are widely used in drug delivery. Nanopharmaceuticals are diverse both in their shape and composition and often offer an advantage as compared to their “bulk” counterparts primarily because of size.
There are two types of nanopharmaceuticals: (1) those where the therapeutic molecules are themselves the drug (i.e.,the therapeutic compound itself also functions as its own carrier); and (2) those where the therapeutic molecules are directly coupled (functionalized, entrapped, or coated) to a nanoparticle carrier.
USA is a huge market, and the total sum of the industry is more than 8756.7 million USD in 2015. At the same time, this industry continuously increases, with the development of global economy.
USA is the largest market of nanopharmaceuticals, which occupies 60.69 percent of global nanopharmaceuticals market share in 2014. It is followed by Europe, which has around 33.37 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
The relatively-mature technology is NanoCrystalsTM, DissCubes® and Nanopure®. The carrier includes nanospheres, nanocapsules, solid lipid nanoparticles, microemulsion, nanoliposome, magnetic nanoparticles, polymeric micelles, dendrimers, and inorganic nanometer carrier.
The global Nanopharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Nanopharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of Nanopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nanopharmaceuticals in these regions.
This research report categorizes the global Nanopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Nanopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3349220-global-nanopharmaceuticals-market-insights-forecast-to-2025
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Market size by Product
Liposomes
Polymeric Micelles
Solid Lipid Nanoparticles
Microemulsion and Nnanoemulsion
Nanosuspension
Market size by End User
Cancer and Tumor
Autoimmune Disorders
Inflammation
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
The study objectives of this report are:
To study and analyze the global Nanopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Nanopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nanopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Nanopharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Leave a Query @ https://www.wiseguyreports.com/enquiry/3349220-global-nanopharmaceuticals-market-insights-forecast-to-2025
Table of Contents
1 Study Coverage
1.1 Nanopharmaceuticals Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nanopharmaceuticals Market Size Growth Rate by Product
1.4.2 Liposomes
1.4.3 Polymeric Micelles
1.4.4 Solid Lipid Nanoparticles
1.4.5 Microemulsion and Nnanoemulsion
1.4.6 Nanosuspension
1.5 Market by End User
1.5.1 Global Nanopharmaceuticals Market Size Growth Rate by End User
1.5.2 Cancer and Tumor
1.5.3 Autoimmune Disorders
1.5.4 Inflammation
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Nanopharmaceuticals Market Size
2.1.1 Global Nanopharmaceuticals Revenue 2014-2025
2.1.2 Global Nanopharmaceuticals Sales 2014-2025
2.2 Nanopharmaceuticals Growth Rate by Regions
2.2.1 Global Nanopharmaceuticals Sales by Regions
2.2.2 Global Nanopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Nanopharmaceuticals Sales by Manufacturers
3.1.1 Nanopharmaceuticals Sales by Manufacturers
3.1.2 Nanopharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global Nanopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Nanopharmaceuticals Revenue by Manufacturers
3.2.1 Nanopharmaceuticals Revenue by Manufacturers (2014-2019)
3.2.2 Nanopharmaceuticals Revenue Share by Manufacturers (2014-2019)
3.3 Nanopharmaceuticals Price by Manufacturers
3.4 Nanopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Nanopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nanopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into Nanopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
….
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck Nanopharmaceuticals Products Offered
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Nanopharmaceuticals Products Offered
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Nanopharmaceuticals Products Offered
11.3.5 Novartis Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Nanopharmaceuticals Products Offered
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Nanopharmaceuticals Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Company Business Overview
11.6.3 Roche Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Roche Nanopharmaceuticals Products Offered
11.6.5 Roche Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Business Overview
11.7.3 Sanofi Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Sanofi Nanopharmaceuticals Products Offered
11.7.5 Sanofi Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Eli Lilly Nanopharmaceuticals Products Offered
11.8.5 Eli Lilly Recent Development
11.9 Astrazeneca
11.9.1 Astrazeneca Company Details
11.9.2 Company Business Overview
11.9.3 Astrazeneca Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Astrazeneca Nanopharmaceuticals Products Offered
11.9.5 Astrazeneca Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Company Business Overview
11.10.3 Johnson & Johnson Nanopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Johnson & Johnson Nanopharmaceuticals Products Offered
11.10.5 Johnson & Johnson Recent Development
11.11 Celgene
11.12 Novavax
11.13 Stryker
11.14 Gilead Sciences
11.15 OSI Pharmaceuticals
11.16 Kadmon Pharmaceuticals
11.17 Samyang Biopharm
11.18 Mitsubishi Pharma
11.19 Kaken Pharmaceutical
11.20 Selecta Biosciences
11.21 Par Pharmaceutical
11.22 Cerulean Pharma
11.23 Navidea Biopharmaceuticals
11.24 Lummy
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3349220
Continued…
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/3349220-global-nanopharmaceuticals-market-insights-forecast-to-2025